DEERFIELD, Ill., Jan. 6, 2010 - Walgreens (NYSE, NASDAQ: WAG) had December sales of $6.3 billion, an increase of 3.6 percent from $6.1 billion for the same month in 2008. Sales in comparable stores (those open at least a year) decreased 0.3 percent. December pharmacy sales increased 4.8 percent, while comparable pharmacy sales increased 1.8 percent. Comparable pharmacy sales were negatively impacted by 2.1 percentage points due to generic drug introductions in the last 12 months. Prescriptions filled at comparable stores increased 4.1 percent in December. Comparable prescriptions filled were positively impacted by 1.1 percentage points due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 59.4 percent of total sales for the month. Total front-end sales increased 1.5 percent in December, while comparable store front-end sales decreased 3.1 percent. The decline in comparable front-end sales was driven primarily by the company's decisio...

DEERFIELD, Ill., Nov. 3, 2009 – Walgreens (NYSE, NASDAQ: WAG) had October sales of $5,650,600,000, an increase of 9.4 percent from $5,164,613,000 for the same month in 2008. Sales in comparable stores (those open at least a year) increased 4.9 percent, while comparable store front-end sales increased 4.7 percent. October pharmacy sales increased 9.3 percent, while comparable pharmacy sales increased 5.0 percent. Comparable pharmacy sales were positively impacted by 1.0 percentage points due to seasonal flu shots, and negatively impacted by 2.2 percentage points due to generic drug introductions in the last 12 months. Prescriptions filled at comparable stores increased 8.6 percent in October, including 2.4 percentage points due to seasonal flu shots and 1.3 percentage points due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 66.3 percent of total sales for the month. The impact of calendar day shifts (not included in the numbers above) had a negati...

DEERFIELD, Ill., Sept. 2, 2009 - Walgreens (NYSE, NASDAQ: WAG) had August sales of $5,228,300,000, an increase of 6.8 percent from $4,893,746,000 for the same month in 2008.  Sales in comparable stores (those open at least a year) increased 1.9 percent. Comparable store front-end sales decreased 1.3 percent. Front-end sales continue to be hurt by slow sales of discretionary items in a challenging economy. August pharmacy sales increased 8.1 percent, while comparable pharmacy sales increased 3.8 percent. Comparable pharmacy sales were negatively impacted by 2.2 percentage points due to generic drug introductions in the last 12 months. Prescriptions filled at comparable stores increased 4.8 percent in August, including 2.0 percentage points due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 66.0 percent of total sales for the month. Calendar day shifts had a positive impact on the month, as August had one extra Monday and ...

DEERFIELD, Ill., July 2, 2009 - Walgreens (NYSE, NASDAQ: WAG) had June sales of $5,236,400,000, an increase of 9.0 percent from $4,804,867,000 for the same month in 2008.  Sales in comparable stores (those open at least a year) increased 3.4 percent. Comparable store front-end sales decreased 0.9 percent versus last year's June increase of 3.4 percent. Front-end sales were hurt by softer sales of seasonal items compared to last year. June pharmacy sales increased 11.0 percent, while comparable pharmacy sales increased 5.8 percent. Comparable pharmacy sales were negatively impacted by 4.4 percentage points due to generic drug introductions in the last 12 months. Prescriptions filled at comparable stores increased 7.5 percent in June, including 1.5 percentage points due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 66.7 percent of total sales for the month. Calendar day shifts had a positive impact on the month, as pharma...

DEERFIELD, Ill., May 4, 2009 - Walgreens (NYSE, NASDAQ: WAG) had April sales of $5,381,000,000, an increase of 11.1 percent from $4,845,355,000 for the same month in 2008. Sales in comparable stores (those open at least a year) rose 5.7 percent, while comparable store front-end sales increased 8.9 percent. Sales were helped by Easter falling in April this year compared with a March Easter last year. Sales for the combined months of March and April 2009 increased 9.0 percent from the same two months in 2008. Comparable store sales for the March/April period rose 3.7 percent, while comparable store front-end sales for the combined months increased 1.3 percent. April pharmacy sales increased 8.5 percent, while comparable pharmacy sales increased 4.0 percent. Comparable pharmacy sales were negatively impacted by 4.0 percentage points due to generic drug introductions in the last 12 months. Total prescriptions filled at comparable stores increased 3.7 percent ...

DEERFIELD, Ill., March 3, 2009 - Walgreens (NYSE, NASDAQ: WAG) had February sales of $5,089,500,000, an increase of 3.4 percent from $4,923,669,000 for the same month in 2008.  Sales in comparable stores (those open at least a year) decreased 1.9 percent, while comparable store front-end sales decreased 3.5 percent. Last year's February sales benefited from one extra day because of leap year. Sales in comparable stores for 28 days this year compared with 28 days last year rose 1.9 percent, while comparable front-end sales for 28 days decreased 0.2 percent. February pharmacy sales increased 3.9 percent, while comparable pharmacy sales decreased 0.9 percent (increased 3.2 percent for 28 days). Comparable pharmacy sales were negatively impacted by 2.2 percentage points due to generic drug introductions in the last 12 months. Total prescriptions filled at comparable stores decreased 3.0 percent (increased 1.0 percent for 28 days). Pharmacy sales accounted for 64.8 percent o...